AUPRES欧珀莱品牌怎么样 申请店铺

我要投票 AUPRES欧珀莱在眼霜行业中的票数:777 更新时间:2025-05-25
AUPRES欧珀莱是哪个国家的品牌?「AUPRES欧珀莱」是资生堂(中国)投资有限公司旗下著名品牌。该品牌发源于上海,由创始人藤原宪太郎在2003期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力AUPRES欧珀莱品牌出海!将品牌入驻外推网,定制AUPRES欧珀莱品牌推广信息,可以显著提高AUPRES欧珀莱产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

AUPRES欧珀莱怎么样

作为国内化妆品市场的主流品牌,欧珀莱自1994年1月推向市场至今,已经在全国一千多家百货商场开设了形象专柜,并在近年保持着高额的年销售增长率,连年荣获全国市场同类产品销售额翘楚桂冠。持续的销售高速增长,使资生堂丽源化妆品有限公司成为日本资生堂集团海外销售成绩最好的公司。欧珀莱也以其卓越的品质、高雅的形象、高质量的服务成为国产化妆品翘楚,在各项评比和检测中得到了专家和消费者的认可。

为满足国内消费者不断增长的美丽需求,公司把研发符合时代需求并基于肌肤本质的护肤品作为产品功能定位,于2008年对“AUPRES/欧珀莱”品牌进行了全面更新,欧珀莱也因此而重获新生。欧珀莱随后不断更新产品系列,并于2012年1月向中国市场推出了凝聚了资生堂研究所历时八年的干细胞研究成果的AUPRESPremium欧珀莱臻源新肌系列,为中国千万女性消费者带来全新“干细胞护理”理念和系列产品,令美肌新生,宛若无龄。

资生堂丽源化妆品有限公司成立于1991年12月9日,作为日本资生堂与北京丽源公司的合资企业,公司秉承资生堂“高品质、高服务、高形象”的企业文化理念,旨在引进日本资生堂的先进技术和科学的经营管理方法,生产经营高知名度、高品质的化妆品,以适应中国市场和国际市场的需求。

1993年,公司在北京经济技术开发区建立工厂,开始在日本资生堂研究所的协助下生产“AUPRES/欧珀莱”系列化妆产品,并以北京为总部,在全国先后建立了21个分公司负责当地及周边地区的销售工作。

在实现经营目标的同时,资生堂丽源也不忘努力回报社会,积极投身各项公益事业,并一贯将环境保护作为企业重要责任,建立环保方针,长期贯彻执行。

资生堂丽源化妆品有限公司将继续坚持“高品质、高服务、高形象”的企业方针,以让消费者满意为宗旨,建立独特的管理机制,生产优质产品,构建周到的服务体系,为顾客提供全方位服务,为打造一流化妆品公司而不懈努力!

As the mainstream brand in the domestic cosmetics market, opale has opened image counters in more than 1000 department stores nationwide since it was introduced to the market in January 1994. It has maintained a high annual sales growth rate in recent years, and has won the title of the top seller of similar products in the national market for years. The continuous rapid growth of sales has made Shiseido Liyuan Cosmetics Co., Ltd. the best overseas sales company of Shiseido group in Japan. Opal has also become the leader of domestic cosmetics with its excellent quality, elegant image and high-quality service, and has been recognized by experts and consumers in various evaluations and tests. In order to meet the growing beauty demand of domestic consumers, the company takes the research and development of skin care products that meet the needs of the times and are based on the nature of skin as the product function orientation. In 2008, the brand "Aupres / opale" was comprehensively updated, and opale was also reborn. Opale then continuously updated its product series, and in January 2012, launched the auprespremium opale Zhenyuan new muscle series to the Chinese market, which combined the eight years of stem cell research results of Shiseido Research Institute, bringing a new "stem cell care" concept and series of products to millions of female consumers in China, making skin beauty new and age-free. Shiseido Liyuan Cosmetics Co., Ltd. was established on December 9, 1991. As a joint venture between Shiseido Japan and Beijing Liyuan company, the company adheres to Shiseido's corporate culture concept of "high quality, high service and high image", aims to introduce advanced technology and scientific management methods of Shiseido Japan, produce and operate high-quality cosmetics with high reputation to adapt to China Market and international market demand. In 1993, the company established a factory in Beijing Economic and Technological Development Zone and began to produce "Aupres / opale" series cosmetics products with the assistance of Shiseido Research Institute of Japan. With Beijing as its headquarters, the company has established 21 branches throughout the country to take charge of the sales work in the local and surrounding areas. At the same time of achieving business objectives, Shiseido Liyuan does not forget to make efforts to return to the society, actively participate in various public welfare undertakings, and always take environmental protection as an important responsibility of the enterprise, establish environmental protection policies, and implement them for a long time. Shiseido Liyuan Cosmetics Co., Ltd. will continue to adhere to the enterprise policy of "high quality, high service and high image", with the purpose of satisfying consumers, establish a unique management mechanism, produce high-quality products, build a thoughtful service system, provide customers with all-round services, and make unremitting efforts to build a first-class cosmetics company!

本文链接: https://brand.waitui.com/9302aacd5.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

科源制药:持股5%以上股东问泽鸿拟减持不超3%公司股份

科源制药5月25日公告,公司持股5%以上股东问泽鸿计划自减持计划公告之日起15个交易日后的3个月内,通过集中竞价及大宗交易方式减持公司股份不超过324.87万股,即不超过公司总股本的3%。其中,通过集中竞价交易方式减持不超过108.29万股,通过大宗交易方式减持不超过216.58万股。减持价格将根据市场价格确定,且不低于发行价。减持原因为自身资金需要。

36分钟前

中信证券:核心资产定价权逐步向南转移

中信证券研报表示,本轮A股公司密集赴港IPO是出海战略、制度便利和港股流动性改善三重力量助推。优质核心资产在港股正式交易后,短期会活跃对应A股的交易,部分核心资产的定价权可能会逐步南移。这个现象的背后是港股市场的吸引力在系统性提升,一是资产供给结构和质量在持续提高,二是流动性在海外资金回流的背景下趋势性改善,从历史上看,港交所每一轮制度的改革突破都带来了顺应时代特征的牛市。未来,更多优质龙头赴港上市可能成为A股市场风格重新转向核心资产的催化剂。

36分钟前

巴基斯坦为比特币挖矿分配2000兆瓦电力装机容量

巴基斯坦在全国范围内支持比特币挖矿和人工智能数据中心的第一阶段计划中,已分配2000兆瓦电力装机容量。目前该国正推动加密货币合法化并吸引外国投资。巴基斯坦财政部在一份声明中表示,这项由巴基斯坦加密货币委员会主导的计划,还将有助于实现剩余能源的货币化并创造高科技就业岗位。财政部称,萨希瓦尔(Sahiwal)、中国枢纽(China Hub)和卡西姆港(Port Qasim)等目前以15%产能运行的燃煤发电项目,预计将被改用于这一计划。(财联社)

36分钟前

众生药业:子公司一类创新药RAY1225注射液两项降糖III期临床试验获伦理批件

5月25日,众生药业公告称,公司控股子公司广东众生睿创生物科技有限公司自主研发的一类创新多肽药物RAY1225注射液用于2型糖尿病(T2DM)患者的两项III期临床试验(SHINING-2和SHINING-3)获得组长单位北京大学人民医院伦理审查批件,批准项目开展。RAY1225注射液是具有全球自主知识产权的创新结构多肽药物,具有GLP-1受体和GIP受体双重激动活性。

36分钟前

存款利率跌破“1”时代,储户转战“新三金”配置

5月下旬,六大国有银行集体下调利率,一年期定存首次跌破1%,活期利率仅0.05%。近一周以来,十余家中小银行紧随大行降息步伐,将最高定存利率压至1.7%以下。部分银行同步调低大额存单利率,并下架2年期以上产品。目前大行大额存单利率多未超过1.4%。部分民营银行调降后,可购大额存单最高利率也仅为1.65%。面对低利率时代,年轻人开始寻找“存款替代”,“货币基金+债基+黄金”的“新三金”配置成为新宠。蚂蚁财富公布的数据显示,截至2025年4月底,有937万90后、00后同时配置了余额宝货币基金、债券基金、黄金基金,“新三金”浪潮持续发酵。(第一财经)

36分钟前

本页详细列出关于AUPRES欧珀莱的品牌信息,含品牌所属公司介绍,AUPRES欧珀莱所处行业的品牌地位及优势。
咨询